Survey of isoniazid preventive therapy in South Africa, 2011

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
J C ChehabJ D Klausner

Abstract

Public health facilities in South Africa. To assess the implementation of isoniazid preventive treatment (IPT) in South Africa in 2011. Cross-sectional study of 50 randomly selected facilities in South Africa. Trained interviewers administered a standardised questionnaire at each facility on aspects of IPT policy, implementation and recording and reporting. We calculated and compared descriptive statistics by province and facility type. Of the 49 participating sites, 35 provided IPT (71%). IPT was not available in any Western Cape facility (0%), and it was available at a few Mpumalanga (40%) and Limpopo (20%) sites. In February 2011, 46% of eligible human immunodeficiency virus (HIV) infected patients at IPT-providing sites had been initiated on IPT. Implementation by facility type was 27% among community health centres. Of all facilities with integrated tuberculosis (TB) and HIV committees (TB-HIV), 85% offered IPT compared to 59% of those without TB-HIV committees (P = 0.12). Availability of the 2010 South African National IPT guidelines was statistically significantly associated with sites providing IPT (84% vs. 29%, P = 0.006). IPT implementation in South Africa began in February 2011. The availability of IPT guidelines was...Continue Reading

Citations

Mar 8, 2013·PloS One·Joel C ChehabJeffrey D Klausner
Jun 3, 2014·BMC Infectious Diseases·Lisa V AdamsKaren R Steingart
Aug 15, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Appolinaire TiamSeble Kassaye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.